Manufacturer record
Moon Marks Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Moon Marks Pharmaceuticals were declared Not of Standard Quality between July 2025 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T-250554, Amoxycillin Dispersible Tablets IP (exp Apr 2027). DTLBikaner (state lab) found it not of standard quality: The sample does not conforms to the I.P. with respect to Assay. Listed in the January 2026 alert.
Records by type
2 records linked to Moon Marks Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin Dispersible Tablets IP | Batch T-250554Mfg May 2025 · Exp Apr 2027 | The sample does not conforms to the I.P. with respect to Assay.Assay | DTLBikanerState lab | Jan 2026 |
| CHLORTHALIDONE TABLETS IP 12.5MG (Ifyclodon -12.5 tablets) | Batch T-241169Mfg Nov 2024 · Exp Oct 2026 | DissolutionDissolution | CDTL, HyderabadCDSCO lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.